To study the functional roles of these T cell-recruiting chemokines, we used neutralizing antibodies to antagonize the expression of CCL5, CXCL9, and CXCL10 in JQ-1-treated tumor-bearing mice. The gene discussed is CCL5; the disease is neoplasm.